Iclazepam
Jump to navigation
Jump to search
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C21H21ClN2O2 |
Molar mass | 368.86 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Iclazepam (Clazepam) is a drug which is a benzodiazepine derivative. It has sedative and anxiolytic effects similar to those produced by other benzodiazepine derivatives, and is around the same potency as chlordiazepoxide.
Iclazepam is a derivative of nordazepam substituted with a cyclopropylmethoxyethyl group on the N1 nitrogen. Once in the body, iclazepam is quickly metabolised to nordazepam and its N-(2-hydroxyethyl) derivative, which are thought to be mainly responsible for its effects.[1]
See also
References
- ^ Giudicelli JF, Berdeaux A, Idrissi N, Richer C (January 1978). "Clazepam: pharmacokinetics and effects on performance". British Journal of Clinical Pharmacology. 5 (1): 65–9. doi:10.1111/j.1365-2125.1978.tb01599.x. PMC 1429233. PMID 23135.
Categories:
- Articles with short description
- Short description matches Wikidata
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Drugs missing an ATC code
- Drugs with no legal status
- Drugboxes which contain changes to watched fields
- Benzodiazepines
- Chloroarenes
- Ethers
- Lactams
- All stub articles
- Sedative stubs